During the past decade, Szent Laszlo Korhaz conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szent Laszlo Korhaz" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 4 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Rigshospitalet, Denmark" with 2 trials sponsored, "CTI BioPharma" with 1 trials sponsored and "Heidelberg Pharma AG" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szent Laszlo Korhaz" #1 collaborator was "Horizon 2020 - European Commission" with 1 trials as a collaborator, "IrsiCaixa" with 1 trials as a collaborator and "University College, London" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Szent Laszlo Korhaz" are "Colorectal Cancer" (3 trials), "AIDS" (2 trials), "Acidosis, Lactic" (1 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Szent Laszlo Korhaz" in a lesser frequency.

Most popular intervention types in "Szent Laszlo Korhaz" are "Drug" (9 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (2 trials), "sorafenib tosylate" (2 trials), "3-dimensional conformal radiation therapy" (1 trials), "Serine Proteinase Inhibitor WX-671" (1 trials) and "Vinorelbine, Oxalplatin, Ifosfasmide, Etoposide, Mitoxatrone, Gemcitabine or Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szent Laszlo Korhaz" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Szent Laszlo Korhaz". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Szent Laszlo Korhaz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szent Laszlo Korhaz, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".